Selective advantage of HIV protease mutations associated with resistance to lopinavir

被引：0
|
作者：
Molla, A. [1 ]
Lu, L. [1 ]
King, M. [1 ]
Woods, R. [2 ]
Pilot-Matias, T. [1 ]
Lam, E. [3 ]
Whitcomb, J. [3 ]
Bernstein, B. [1 ]
Hanna, G. [1 ]
Kempf, D. [1 ]
机构：
[1] Global Pharmaceut Res & Dev, Abbott Pk, IL USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Monogram Biosci, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] Selective advantage of HIV protease mutations associated with resistance to lopinavir
    Molla, A.
    Lu, L.
    King, M.
    Woods, R.
    Pilot-Matias, T.
    Lam, E.
    Whitcomb, J.
    Bernstein, B.
    Hanna, G.
    Kempf, D.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S85 - S85
  • [2] Mutations in HIV-1 protease associated with resistance to amprenavir contribute towards phenotypic resistance to lopinavir
    Parkin, NT
    Chappey, C
    Petropoulos, CJ
    ANTIVIRAL THERAPY, 2002, 7 : S29 - S29
  • [3] Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor
    Barber, Tristan J.
    Harrison, Linda
    Asboe, David
    Williams, Ian
    Kirk, Stuart
    Gilson, Richard
    Bansi, Loveleen
    Pillay, Deenan
    Dunn, David
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 995 - 1000
  • [4] Signature substrate mutations associated with HIV-1 protease inhibitor resistance
    Kolli, M.
    Stawiski, E.
    Chappey, C.
    Parkin, N.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 : S144 - S144
  • [5] Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance
    Mellors, JW
    Larder, BA
    Schinazi, R
    Deverson, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 92 - 92
  • [6] Signature substrate mutations associated with HIV-1 protease inhibitor resistance
    Kolli, M.
    Stawiski, E.
    Chappey, C.
    Parkin, N.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S144 - S144
  • [7] HIV-1 protease with 10 lopinavir and darunavir resistance mutations exhibits altered inhibition, structural rearrangements and extreme dynamics
    Wong-Sam, Andres
    Wang, Yuan -Fang
    Kneller, Daniel W.
    Kovalevsky, Andrey Y.
    Ghosh, Arun K.
    Harrison, Robert W.
    Weber, Irene T.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 117
  • [8] Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
    Lopes, J.
    Goncalves, F.
    Cabanas, J.
    Costa, I.
    Fernandes, S.
    Diogo, I.
    Pingarilho, M.
    Gomes, P.
    ANNALS OF MEDICINE, 2021, 53 : S120 - S120
  • [9] HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1
    Pieniazek, D
    Rayfield, M
    Hu, DJ
    Nkengasong, JN
    Soriano, V
    Heneine, W
    Zeh, C
    Agwale, SM
    Wambebe, C
    Odama, L
    Wiktor, SZ
    Kalish, ML
    AIDS, 2004, 18 (03) : 495 - 502
  • [10] Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens
    Santos, Jose R.
    Llibre, Josep M.
    Imaz, Arkaitz
    Domingo, Pere
    Iribarren, Jose A.
    Marino, Ana
    Miralles, Celia
    Galindo, Maria J.
    Ornelas, Arelly
    Moreno, Santiago
    Schapiro, Jonathan M.
    Clotet, Bonaventura
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1462 - 1469
12345